We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Caterpillar
CAT
$409B
| $9.17M | 0.05% |
103,276
+3,934
| +4% | +$322K |
|
352
Adobe
ADBE
$89.5B
| $9.12M | 0.05% |
84,021
-8,193
| -9% | -$822K |
|
353
AstraZeneca
AZN
$263B
| $9.09M | 0.05% |
138,413
-1,731
| -1% | -$113K |
|
|
SI
354
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $9.05M | 0.05% |
77,282
+3,875
| +5% | +$454K |
|
355
Bath & Body Works
BBWI
$4.01B
| $8.99M | 0.05% |
157,240
-433
| -0.3% | -$25.5K |
|
356
TotalEnergies
TTE
$193B
| $8.89M | 0.05% |
186,446
+10,346
| +6% | +$494K |
|
357
ANI Pharmaceuticals
ANIP
$1.77B
| $8.86M | 0.05% |
+133,493
| New | +$8.35M |
|
358
ConocoPhillips
COP
$147B
| $8.79M | 0.05% |
202,281
-109,170
| -35% | -$4.54M |
|
|
UPM
359
DELISTED
UPM-KYMMRME ADR (REPR ORD SHS)
UPM
| $8.69M | 0.05% |
411,461
+30,022
| +8% | +$634K |
|
360
WPP
WPP
$4.04B
| $8.31M | 0.05% |
70,632
+5,578
| +9% | +$636K |
|
|
AMCR
361
DELISTED
AMCOR LTD ADR
AMCR
| $8.31M | 0.05% |
179,160
+13,437
| +8% | +$623K |
|
|
STI
362
DELISTED
SunTrust Banks, Inc.
STI
| $8.2M | 0.05% |
187,225
-151,696
| -45% | -$6.5M |
|
|
TKP
363
DELISTED
TECHNIP ADS (EA REPTG ONE ORD SHS)
TKP
| $8.15M | 0.05% |
531,009
+217,111
| +69% | +$3.33M |
|
364
Novartis
NVS
$295B
| $8.12M | 0.05% |
114,822
-6,487
| -5% | -$473K |
|
365
Cummins
CMI
$91.7B
| $8.05M | 0.05% |
62,864
+5,177
| +9% | +$628K |
|
|
LPT
366
DELISTED
Liberty Property Trust
LPT
| $7.91M | 0.04% |
196,127
-9,504
| -5% | -$384K |
|
|
TPC
367
Tutor Perini Cor
TPC
$4.57B
| $7.9M | 0.04% |
+368,075
| New | +$8.58M |
|
368
WEC Energy
WEC
$37.7B
| $7.84M | 0.04% |
131,042
+100,146
| +324% | +$6.25M |
|
369
British American Tobacco
BTI
$132B
| $7.77M | 0.04% |
121,772
+5,828
| +5% | +$369K |
|
370
Duke Energy
DUK
$102B
| $7.73M | 0.04% |
96,598
+7,169
| +8% | +$594K |
|
371
General Mills
GIS
$19.2B
| $7.63M | 0.04% |
119,492
+7,839
| +7% | +$545K |
|
|
VAR
372
DELISTED
Varian Medical Systems, Inc.
VAR
| $7.56M | 0.04% |
86,628
-25,811
| -23% | -$2.1M |
|
373
Brixmor Property Group
BRX
$9.95B
| $7.51M | 0.04% |
270,313
+40,826
| +18% | +$1.14M |
|
374
DTE Energy
DTE
$31.1B
| $7.49M | 0.04% |
94,016
+2,635
| +3% | +$215K |
|
375
Graco
GGG
$12.9B
| $7.42M | 0.04% |
300,915
+3,207
| +1% | +$80.2K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.